Get your Emails warmed up and ready to send
Build sender reputation and reach more inboxes with automated email warmup.
Warm up your emails
Starting at $49/month
Michal Janiszewski
Director, Clinical Research - Eastern Europe @Iterative Health
Signup · Get unlimited contacts
WORK HISTORY
Director, Clinical Research - Eastern Europe @Iterative Health
PL
Spearheading the development and implementation of the medical affairs strategy for clinical trials, ensuring alignment with organizational goals.* Collaborating with the team to identify and prioritize clinical research opportunities.* Providing guidance and oversight for clinical studies and their execution.* Working with clinical operations, regulatory affairs, and pharmacovigilance teams to ensure compliance with regulatory standards.* Overseeing the preparation and initiation of clinical trial activities.* Monitoring and evaluating clinical trial performance, ensuring adherence to timelines, budgets, and quality standards.* Building and maintaining strong relationships with external stakeholders including key opinion leaders (KOLs), investigators, and research organizations.* Coordinating with commercial and development teams to ensure alignment on product strategy and scientific messaging.* Leading the preparation and dissemination of scientific information related to clinical studies, including conference presentations.* Providing training and support for both internal and external teams on study-related information and medical insights.* Engaging in medical education initiatives to enhance understanding of the clinical landscape.* Partnering with regulatory affairs to ensure compliance with regulatory requirements and facilitating communication with health authorities.
EDUCATION
The University of Edinburgh
Doctor of Philosophy (Ph.D.), Genetics and Cell Biology
Edinburgh Napier University
Bachelor’s Degree, Microbiology and Biotechnology
ABOUT MICHAL JANISZEWSKI
Highly accomplished and results-driven Director of Clinical Research - Eastern Europe at Iterative Health, where I leverage my expertise in gastrointestinal tract diseases, fatty liver, and obesity, combined with cutting-edge AI technology, to advance clinical science. This role marks an exciting transition from preclinical to clinical science, enabling me to make significant contributions to gastroenterology and patient care.Previously, as the Head of the Metabolic Diseases Research Group, I harnessed my strong background in diabetes, medical genetics, drug development, and R&D strategy. With over a decade of experience in the science/pharmaceutical industry, I have consistently driven innovation and successfully guided preclinical programs from their inception to regulatory approval.As a strategic leader, I excel in crafting and executing robust research strategies that optimize resources and accelerate drug discovery and development. My proven ability to translate scientific concepts into actionable plans, encourage cross-functional collaboration, and achieve critical milestones within budget and timelines underscores my leadership.Driven by a passion for advancing novel therapeutics and improving patient outcomes, I thrive in dynamic environments that foster innovation and emphasize a multidisciplinary approach to problem-solving. Leading high-performing teams and driving transformative discoveries have always been central to my career.Let’s connect to explore collaboration opportunities, share insights, and contribute to the advancement of both preclinical and clinical research for transformative drug development.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.